Proinflammatory and Hepatic Features Related to Morbidity and Fatal Outcomes in COVID-19 Patients.

Omar Ramos-López Rodrigo San-CristóbalDiego Martinez-UrbistondoVíctor Micó Gonzalo ColmenarejoPaula Villares-FernandezLidia Daimiel RuizJ Alfredo Martinez

Published in: Journal of clinical medicine (2021)

the results of this research revealed that liver and proinflammatory features are important determinants of COVID-19 morbidity and fatal outcomes, which could improve the current understanding of the COVID-19 physiopathology as well as to facilitate the clinical management and therapy decision-making of this disease under a personalized medicine scope.

Keyphrases

sars cov
coronavirus disease
decision making
respiratory syndrome coronavirus
single cell
mesenchymal stem cells
metabolic syndrome
cell therapy
glycemic control
insulin resistance
bone marrow
weight loss
smoking cessation
drug induced